Want Cliffs Notes on health reform? Look at Wishard
Soon to change its name to Eskenazi Health, the county-owned hospital in Indianapolis is using a business model that tries to promote patients’ health, rather than merely treat their diseases.
Life Science & Biotech
Articles
Obama hands employers free play on health insurance
The Obama administration’s one-year delay on enforcement of penalties against employers that fail to offer affordable health insurance gives employers the chance to cancel their benefits for the year and pocket a boatload of cash.
Call the midwife: Doctors, hospitals, patients all guilty of driving up childbirth costs
I can see the business model of the physicians and hospitals at work as they recommend tests of questionable necessity. Yet when it’s my own wife and son, it’s easy to think of a terrible outcome to avert with just one more test.
Universities’ patents often lack commercial applications
The state's universities crank out patents that find their way to pharmaceutical, prosthetics and surgery technology companies. But they also generate reams of patents in areas with few industrial applications.
Cook Group looking forward to next 50 years
For leaders of a company looking back on 50 years of existence, Cook Group President Kem Hawkins and Chairman Steve Ferguson spend a lot of time talking about the future.
Physician pay: What goes up must come down
Compensation in the most common physician specialties has been growing much faster than inflation for the past five years. Now, financially squeezed hospitals are set to reverse that trend.
Lilly Endowment to give $10M to start biosciences institute
The institute aims to attract 100 new scientists to Indiana to conduct research and development work aimed at launching new therapies for metabolic diseases.
Me-too diabetes drugs look good enough for Lilly
Eli Lilly and Co. is more than 15 years late to the game in the world of diabetes drugs. And it isn’t bringing much that doctors and patients haven’t already seen. Still, that might be good enough to make a few billion a year.
WellPoint’s respite from criticism will be short-lived
With recent attention focused on hospital prices, WellPoint and its peers have been enjoying a nice break from their long-running status as Public Enemy No. 1 in the nation’s health care debate. They shouldn’t expect it to last.
IT revolution coming to local health care
Local providers will increasingly look for help from IT firms like Indigo Biosystems Inc. and VoCare Inc. as part of a coming wave of health IT innovation that is likely to mirror the IT revolution that began 30 years ago.
Medicare report a fresh threat to local hospital finances
A new recommendation from the Medicare Payment Advisory Commission, if enacted, would likely end one of the ways Indianapolis-area hospitals have generated healthy revenue from their recent spree of physician acquisitions.
Hospitals, insurers should end hide-and-seek with prices
To get control of health care spending, prominent health policy wonks are calling for new rules requiring hospitals and insurers to raise the ‘veil of secrecy’ they have thrown over their prices for decades.
Lilly halts trial of experimental Alzheimers drug
The trial ended after participants showed abnormal liver biochemistry, the Indianapolis-based drugmaker said Thursday in a statement.
Most of Indiana’s largest public companies enjoyed strong 2012
Angie’s List turned a profit for the first time in nearly two decades.
232,000 Hoosiers hang in balance in Pence-Obama wrangling over Medicaid
New analysis shows Obamacare would cut state’s uninsured rolls 49 percent, compared with just 18 percent if Gov. Mike Pence opts out of a Medicaid expansion.
Bio-Response expanding in Hendricks County
Wastewater equipment maker is moving to a Danville business park to build a $1.1 million facility.
Hospitals proving themselves wrong about prices
Whenever a new report claims hospitals are charging too much, a stock set of defenses comes out. But hospitals are cutting prices and expenses as we speak, undermining those arguments.
Are employers ready to limit workers’ choice of doctor?
The real test of so-called narrow network health plans will come not with Obamacare's exchanges, but with employers, who control a far bigger slice of the health benefits pie and have been highly reluctant to limit their workers' choice of hospitals and doctors.
New institute aims to attract 100 research scientists to Indiana
The $360 million initiative will be formally launched on Thursday by Gov. Mike Pence, executives of five major life sciences companies and officials of the state’s research universities.